Quel est le prix pour Heat Biologics, Inc. (HTBX)

Le prix pour Heat Biologics, Inc. (HTBX) est $2.38

Quelle est la capitalisation boursière pour Heat Biologics, Inc. (HTBX)

La capitalisation boursière pour Heat Biologics, Inc. (HTBX) est $61.07M

Heat Biologics, Inc. (HTBX) Historique des Prix

Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two key components: ImPACT, an allogenic cell-based system designed to stimulate and proliferate T-cells as an immune activator, and ComPACT, a singular product engineered to achieve both antigen-driven T-cell activation and specific co-stimulation simultaneously. Their development pipeline includes several clinical-stage assets. HS-110 has finished enrolling patients for its Phase II trial targeting advanced non-small cell lung cancer, while HS-130 is currently in a Phase I clinical trial for advanced solid tumors. Furthermore, PTX-35, a novel T-cell co-stimulator agonist antibody that acts on DR3/TNFRSF25, is being evaluated in a Phase I clinical trial for diverse immunotherapy applications. The company is also advancing a COVID-19 vaccine, which is currently in the preclinical stage. Heat Biologics, Inc. has partnered with Dr. James Shapiro at the University of Alberta to develop a surrogate mouse version of PTX-35. The company was founded in 2008 and is headquartered in Morrisville, North Carolina.

Année	Performance
2022	-38.25%
2021	-38.90%
2020	95.34%
2019	-61.23%
2018	-69.52%
2017	-58.03%
2016	-61.70%
2015	-42.63%
2014	-45.31%
2013	0.00%

Année

Performance

2022

-38.25%

2021

-38.90%

2020

95.34%

2019

-61.23%

2018

-69.52%

2017

-58.03%

2016

-61.70%

2015

-42.63%

2014

-45.31%

2013

0.00%

Entreprise	Prix de l'action	Variation 1a%	Pays
Vertex Pharmaceuticals Incorporated VRTX.US	$547.71	38.62%	US
Argenx SE ARGX.US	$1.04K	58.06%	NL
Moderna, Inc. MRNA.US	$145.75	437.43%	US
CSL Limited CSL.AX	$118.70	-15.60%	AU
Lonza Group AG LONN.SW	$770.19	8.98%	CH

Entreprise

Prix de l'action

Variation 1a%

Pays